The diagnosis and treatment of type 2 diabetes is becoming ever more complex. Proposed changes in how we diagnose the condition, newly identified dangers in attempting to achieve QOF indicators, several new therapies from which to choose and the need to address the “glucose triad” of HbA1c, fasting and postprandial plasma glucose levels all point to serious challenges ahead. These practical workshops use both lectures and interactive case study scenarios to address the major hurdles we face when making clinical decisions at “the coalface”. By focusing on the practice, rather than the theory, we aim to help you tackle the issues that influence the lives of people with type 2 diabetes. What, in fact, are their concerns? Are these necessarily the same as ours? And how can both be addressed together?

Learning objectives:
After participating in one of these events, you will able to:
• Identify the clinical and financial impact of proposed changes in the way diabetes is diagnosed.
• Recognise how to maximise QOF points available for diabetes care safely, remembering that, in terms of glycaemic control, one person’s “low” may be another’s “too low”.
• Appropriately tailor your approach to glycaemic control in people with type 2 diabetes taking account of factors such as age, ethnicity, vocation, lifestyle and comorbidities.

We look forward to welcoming you to an event near you.
Martin Hadley-Brown, David Haslam, Richard Quigley, Co-Chairs

Sponsored and developed by Bristol-Myers Squibb and AstraZeneca, in conjunction with Diabetes & Primary Care journal.

Places are limited and will be assigned on a first-come first-served basis.

422EMEA10PM020  CZ004035c-ONGL  July 2010